Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis

Tirdad T. Zangeneh, Joshua Malo, Carmen Luraschi-Monjagatta, Chadi Hage, L. Joseph Wheat, Christopher Strawter, Stephen A. Klotz, Kenneth S. Knox

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Fungal antigen testing in immunosuppressed patients has emerged as a powerful diagnostic tool. Some assays are relatively nonspecific, and misinterpretation can have severe clinical consequences. Additionally, when new assays become commercially available it is important to evaluate the potential for cross reactivity. We recently observed several immunosuppressed patients with positive (1→3)-β-D-glucan (BG) who were eventually diagnosed with coccidioidomycosis in the endemic area of Tucson, Arizona. Although the BG assay is known to detect glucans of many fungal pathogens, reports of cross-reactivity with Coccidioides remain sparsely reported. To test the cross-reactivity of fungal antigens in detection assays, serum samples from patients with coccidioidomycosis testing positive for Coccidioides antigen were evaluated for BG. Of 12 samples positive for Coccidioides antigen (≥ 0.07 ng/ml), 11 (92%) were positive by BG (>80 pg/ml), and of 11 positive for Aspergillus galactomannan, 10 (91%) were positive by BG (>80 pg/ml). We conclude that the BG assay is nonspecific, detecting glucans from many fungal pathogens, including Coccidioides. In the endemic area, a positive BG warrants further specific testing.

Original languageEnglish (US)
Pages (from-to)171-173
Number of pages3
JournalMedical Mycology
Volume53
Issue number2
DOIs
StatePublished - Oct 18 2015

Fingerprint

Coccidioides
coccidioidomycosis
Coccidioidomycosis
Glucans
glucans
cross reaction
Fungal Antigens
fungal antigens
assays
antigen detection
Antigens
antigens
Aspergillus
testcrosses
pathogens
testing
sampling
Serum

Keywords

  • Coccidioidomycosis
  • galactomannan
  • glucan
  • immunoassay

ASJC Scopus subject areas

  • veterinary(all)
  • Infectious Diseases
  • Medicine(all)

Cite this

Zangeneh, T. T., Malo, J., Luraschi-Monjagatta, C., Hage, C., Wheat, L. J., Strawter, C., ... Knox, K. S. (2015). Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis. Medical Mycology, 53(2), 171-173. https://doi.org/10.1093/mmy/myu077

Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis. / Zangeneh, Tirdad T.; Malo, Joshua; Luraschi-Monjagatta, Carmen; Hage, Chadi; Wheat, L. Joseph; Strawter, Christopher; Klotz, Stephen A.; Knox, Kenneth S.

In: Medical Mycology, Vol. 53, No. 2, 18.10.2015, p. 171-173.

Research output: Contribution to journalArticle

Zangeneh, TT, Malo, J, Luraschi-Monjagatta, C, Hage, C, Wheat, LJ, Strawter, C, Klotz, SA & Knox, KS 2015, 'Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis', Medical Mycology, vol. 53, no. 2, pp. 171-173. https://doi.org/10.1093/mmy/myu077
Zangeneh TT, Malo J, Luraschi-Monjagatta C, Hage C, Wheat LJ, Strawter C et al. Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis. Medical Mycology. 2015 Oct 18;53(2):171-173. https://doi.org/10.1093/mmy/myu077
Zangeneh, Tirdad T. ; Malo, Joshua ; Luraschi-Monjagatta, Carmen ; Hage, Chadi ; Wheat, L. Joseph ; Strawter, Christopher ; Klotz, Stephen A. ; Knox, Kenneth S. / Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis. In: Medical Mycology. 2015 ; Vol. 53, No. 2. pp. 171-173.
@article{e9dec3e3490d45859f01c25c033e8824,
title = "Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis",
abstract = "Fungal antigen testing in immunosuppressed patients has emerged as a powerful diagnostic tool. Some assays are relatively nonspecific, and misinterpretation can have severe clinical consequences. Additionally, when new assays become commercially available it is important to evaluate the potential for cross reactivity. We recently observed several immunosuppressed patients with positive (1→3)-β-D-glucan (BG) who were eventually diagnosed with coccidioidomycosis in the endemic area of Tucson, Arizona. Although the BG assay is known to detect glucans of many fungal pathogens, reports of cross-reactivity with Coccidioides remain sparsely reported. To test the cross-reactivity of fungal antigens in detection assays, serum samples from patients with coccidioidomycosis testing positive for Coccidioides antigen were evaluated for BG. Of 12 samples positive for Coccidioides antigen (≥ 0.07 ng/ml), 11 (92{\%}) were positive by BG (>80 pg/ml), and of 11 positive for Aspergillus galactomannan, 10 (91{\%}) were positive by BG (>80 pg/ml). We conclude that the BG assay is nonspecific, detecting glucans from many fungal pathogens, including Coccidioides. In the endemic area, a positive BG warrants further specific testing.",
keywords = "Coccidioidomycosis, galactomannan, glucan, immunoassay",
author = "Zangeneh, {Tirdad T.} and Joshua Malo and Carmen Luraschi-Monjagatta and Chadi Hage and Wheat, {L. Joseph} and Christopher Strawter and Klotz, {Stephen A.} and Knox, {Kenneth S.}",
year = "2015",
month = "10",
day = "18",
doi = "10.1093/mmy/myu077",
language = "English (US)",
volume = "53",
pages = "171--173",
journal = "Medical Mycology",
issn = "1369-3786",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Positive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis

AU - Zangeneh, Tirdad T.

AU - Malo, Joshua

AU - Luraschi-Monjagatta, Carmen

AU - Hage, Chadi

AU - Wheat, L. Joseph

AU - Strawter, Christopher

AU - Klotz, Stephen A.

AU - Knox, Kenneth S.

PY - 2015/10/18

Y1 - 2015/10/18

N2 - Fungal antigen testing in immunosuppressed patients has emerged as a powerful diagnostic tool. Some assays are relatively nonspecific, and misinterpretation can have severe clinical consequences. Additionally, when new assays become commercially available it is important to evaluate the potential for cross reactivity. We recently observed several immunosuppressed patients with positive (1→3)-β-D-glucan (BG) who were eventually diagnosed with coccidioidomycosis in the endemic area of Tucson, Arizona. Although the BG assay is known to detect glucans of many fungal pathogens, reports of cross-reactivity with Coccidioides remain sparsely reported. To test the cross-reactivity of fungal antigens in detection assays, serum samples from patients with coccidioidomycosis testing positive for Coccidioides antigen were evaluated for BG. Of 12 samples positive for Coccidioides antigen (≥ 0.07 ng/ml), 11 (92%) were positive by BG (>80 pg/ml), and of 11 positive for Aspergillus galactomannan, 10 (91%) were positive by BG (>80 pg/ml). We conclude that the BG assay is nonspecific, detecting glucans from many fungal pathogens, including Coccidioides. In the endemic area, a positive BG warrants further specific testing.

AB - Fungal antigen testing in immunosuppressed patients has emerged as a powerful diagnostic tool. Some assays are relatively nonspecific, and misinterpretation can have severe clinical consequences. Additionally, when new assays become commercially available it is important to evaluate the potential for cross reactivity. We recently observed several immunosuppressed patients with positive (1→3)-β-D-glucan (BG) who were eventually diagnosed with coccidioidomycosis in the endemic area of Tucson, Arizona. Although the BG assay is known to detect glucans of many fungal pathogens, reports of cross-reactivity with Coccidioides remain sparsely reported. To test the cross-reactivity of fungal antigens in detection assays, serum samples from patients with coccidioidomycosis testing positive for Coccidioides antigen were evaluated for BG. Of 12 samples positive for Coccidioides antigen (≥ 0.07 ng/ml), 11 (92%) were positive by BG (>80 pg/ml), and of 11 positive for Aspergillus galactomannan, 10 (91%) were positive by BG (>80 pg/ml). We conclude that the BG assay is nonspecific, detecting glucans from many fungal pathogens, including Coccidioides. In the endemic area, a positive BG warrants further specific testing.

KW - Coccidioidomycosis

KW - galactomannan

KW - glucan

KW - immunoassay

UR - http://www.scopus.com/inward/record.url?scp=84925138205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925138205&partnerID=8YFLogxK

U2 - 10.1093/mmy/myu077

DO - 10.1093/mmy/myu077

M3 - Article

C2 - 25541557

AN - SCOPUS:84925138205

VL - 53

SP - 171

EP - 173

JO - Medical Mycology

JF - Medical Mycology

SN - 1369-3786

IS - 2

ER -